sTARTUp Day 2023

15 - 17 March, 2023 | Tartu

We are pleased to announce that we will be joining sTARTUp Day 2023 as speakers. This unique event will bring together startup-minded people to celebrate entrepreneurship in the city of Tartu.

Our speakers Chus Castillo Gutierrez, VP Global Market Access Iberia, and Isabel De La Paz, Associate Director, GMA, will lead a seminar titled “Insider’s tips about Spanish health tech market? Key points you need to keep in mind, when thinking of conquering the Spanish (and the Portuguese) health tech market”.

About the seminar:

Both Spain and Portugal follow the Beveridge healthcare model, in which public healthcare is funded by the general state budget through taxes and provided under conditions of universality, equity and gratitude.

In both countries, public and private healthcare systems coexist, with the public sector having a greater weight in both countries (around 75%).

These particularities make both markets extremely attractive because the financing of new technologies implies that a high volume of patients can access health technology or biotechnological products.

However, in both countries, the procedures for obtaining regulatory approval and funding are complex, and a lack of knowledge and preparation can cause long delays in patients’ access.

In this seminar we will guide you on how to successfully enter the Spanish market and will share how to:

  • Flow through the regulatory process
  • Master the HTA evaluation: How to prepare a great value communication strategy and a successful price strategy
  • Catalyze access: Innovation Fast track strategies
  • Manage entry agreements
  • Manage innovative public procurement processes
  • Understand Early Access Programs
  • Find regional strategic partners in the biotech and Health Tech sector.
Published on:
February 21, 2023
Our speakers:
Chus Castillo

Chus Castillo Gutierrez

VP Global Market Access Iberia Chus has more than 35 years of experience in the pharmaceutical industry, including management roles for biotech and big pharma companies in Spain. His expertise is in industry strategy, R&D, regulatory, marketing and sales, public affairs, and market access. With a track record of over 150 transactions across a range of consulting assignments, Chus’s work includes national and international projects in the U.S. and the EU 5.

He holds a degree in Biology and Pharmacy from the University of Barcelona, and an MBA from EADA Business School, including courses in HEOR and Pharmaeconomy.
Isabel De La Paz

Isabel De La Paz 

Associate Director, GMA Isabel is an expert in the evaluation of drugs and pharmaceutical technologies, health care management, drug policy, and strategy setting. She is a Board-Certified Oncology Pharmacist (BCOP), Oncology & Oncio-Haemathology and holds Master's Degree in Clinical, Hospital, and Managed Care Pharmacy from University of Granada (Spain).
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.